Opportunity Information: Apply for PAR 16 317
Apply for PAR 16 317
- The HHS-NIH11 in the education, health sector is offering a public funding opportunity titled "Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395, 93.399,.
- This funding opportunity was created on Jun 08, 2016 and posted on Jun 08, 2016.
- Applicants must submit their applications by Apr 11, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)" (Funding Opportunity Number PAR-16-317) is a discretionary NIH research grant issued under the U.S. Department of Health and Human Services. It focuses on intervention research that directly supports caregivers of adult cancer patients, with the idea that better-supported caregivers can improve both patient outcomes and the way health care services are used. The announcement was posted on June 8, 2016, and the listed application due date (closing date) was April 11, 2019.
At its core, this opportunity is about designing, testing, and evaluating interventions that help cancer caregivers do their role more effectively and with less personal strain. The FOA explicitly highlights caregiver-oriented strategies such as practical care training (so caregivers can more confidently handle day-to-day care tasks and coordination responsibilities), skill-building around coping and stress management (to reduce burden and improve resilience), and broader supports that help caregivers manage the ongoing demands of cancer care. The interventions funded through this mechanism are meant to be structured programs or approaches that can be studied rigorously, rather than purely descriptive studies or general service delivery without an evaluative research component.
The FOA ties caregiver support to three major outcome areas. First, it aims to optimize patient health care utilization, meaning interventions should plausibly reduce avoidable or inefficient use of health care resources, such as preventable emergency department visits, unplanned hospitalizations, complications that could be mitigated with better home management, or breakdowns in care coordination. Second, it seeks to improve caregiver well-being, which can include outcomes like reduced stress, anxiety, depression, or burnout; improved quality of life; increased confidence or self-efficacy in the caregiving role; and better overall functioning. Third, it targets improved patient outcomes, both physical and psychosocial, recognizing that caregiver capacity and stability can influence symptom management, adherence to treatment plans, recovery, emotional adjustment, and the overall experience of care for the patient.
This is an R01 funding mechanism, which generally supports substantial, hypothesis-driven research projects with enough scope to develop and test an intervention using strong study designs. While the specific ceiling and number of anticipated awards are not provided in the source text, the R01 format typically implies a multi-year research plan with clear aims, defined intervention components, appropriate comparison conditions when feasible, and measurable outcomes aligned with the FOA priorities (utilization, caregiver well-being, and patient health/psychosocial results).
Eligibility is broad and includes many types of domestic organizations that can conduct research. Eligible applicants listed include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those categories); small businesses; for-profit organizations other than small businesses; public housing authorities/Indian housing authorities; and Native American tribal governments (federally recognized) as well as other tribal organizations. The FOA also references an "Others" category with additional clarification in the full announcement, implying that additional entity types may be eligible depending on NIH policy and FOA-specific language.
The program is categorized under Education and Health funding activity areas and is associated with CFDA numbers 93.395 and 93.399, which are NIH assistance listing identifiers related to cancer research and NIH research support more broadly. Overall, the opportunity is aimed at generating evidence-based, caregiver-centered interventions that not only support the caregiver as an individual but also measurably improve the patient-caregiver system in ways that translate into better health outcomes and more appropriate, efficient use of health care services.
FAQs: Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01) (PAR-16-317)
What is the title of this grant opportunity?
The opportunity is titled "Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PAR-16-317.
Which federal agency is offering this grant?
This is a discretionary NIH research grant issued under the U.S. Department of Health and Human Services.
What type of grant mechanism is this?
This opportunity uses the NIH R01 mechanism, which generally supports substantial, hypothesis-driven research projects with enough scope to develop and test an intervention using strong study designs.
When was this opportunity posted?
The announcement was posted on June 8, 2016.
What was the listed application due date (closing date)?
The listed application due date (closing date) was April 11, 2019.
What is the main purpose of this FOA?
The focus is on intervention research that directly supports caregivers of adult cancer patients, based on the idea that better-supported caregivers can improve patient outcomes and optimize how health care services are used.
Who are the primary beneficiaries of the interventions being studied?
The interventions are caregiver-centered and directly support caregivers of adult cancer patients, with intended downstream benefits for both the patient and the health care system.
What kind of research does the FOA emphasize?
It emphasizes designing, testing, and evaluating structured interventions that help cancer caregivers perform their role more effectively and with less personal strain, using rigorous study approaches.
Does the FOA support descriptive studies or general service delivery programs without evaluation?
The FOA is geared toward structured programs or approaches that can be studied rigorously, rather than purely descriptive studies or general service delivery that lacks an evaluative research component.
What types of caregiver-focused strategies are specifically highlighted?
The FOA explicitly highlights caregiver-oriented strategies such as practical care training (to help caregivers handle day-to-day care tasks and coordination), skill-building around coping and stress management (to reduce burden and improve resilience), and broader supports that help caregivers manage the ongoing demands of cancer care.
What outcome areas does the FOA connect to caregiver support?
The FOA ties caregiver support to three major outcome areas: (1) optimizing patient health care utilization, (2) improving caregiver well-being, and (3) improving patient outcomes (physical and psychosocial).
What does "optimize patient health care utilization" mean in this context?
It refers to interventions that could plausibly reduce avoidable or inefficient use of health care resources, such as preventable emergency department visits, unplanned hospitalizations, complications that could be mitigated with better home management, or breakdowns in care coordination.
What kinds of caregiver well-being outcomes are relevant to this FOA?
Examples mentioned include reduced stress, anxiety, depression, or burnout; improved quality of life; increased confidence or self-efficacy in the caregiving role; and better overall functioning.
What kinds of patient outcomes does the FOA aim to improve?
The FOA targets improved patient outcomes both physical and psychosocial, recognizing that caregiver capacity can influence symptom management, adherence to treatment plans, recovery, emotional adjustment, and the overall experience of care.
What population of patients is specified?
The FOA focuses on caregivers of adult cancer patients.
What level of project scope is implied by the R01 format?
The R01 format typically implies a multi-year research plan with clear aims, defined intervention components, appropriate comparison conditions when feasible, and measurable outcomes aligned with the FOA priorities (utilization, caregiver well-being, and patient outcomes).
Is there a stated funding ceiling or expected number of awards in the provided information?
No. The provided information notes that the specific ceiling and the number of anticipated awards are not included in the source text.
Who is eligible to apply?
Eligibility is broad and includes many types of domestic organizations that can conduct research.
Which government entities are eligible applicants?
Eligible applicants include state governments, county governments, city or township governments, special district governments, and Native American tribal governments (federally recognized).
Are educational institutions eligible?
Yes. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and independent school districts.
Are nonprofits eligible to apply?
Yes. Nonprofit organizations with or without 501(c)(3) status are listed as eligible (excluding higher education institutions in those nonprofit categories, as stated in the provided information).
Are businesses eligible to apply?
Yes. Eligible applicants include small businesses and for-profit organizations other than small businesses.
Are housing authorities eligible to apply?
Yes. Public housing authorities and Indian housing authorities are listed as eligible applicants.
Are tribal organizations (other than federally recognized tribal governments) included?
Yes. The eligibility list includes "other tribal organizations" in addition to federally recognized tribal governments.
What does the FOA mean by an "Others" eligibility category?
The FOA references an "Others" category with additional clarification in the full announcement, suggesting that additional entity types may be eligible depending on NIH policy and FOA-specific language.
What are the funding activity areas associated with this opportunity?
The program is categorized under Education and Health funding activity areas.
What CFDA (Assistance Listing) numbers are associated with this grant?
The opportunity is associated with CFDA numbers 93.395 and 93.399, described as NIH assistance listing identifiers related to cancer research and NIH research support more broadly.
What is the overall intent of the research supported by this FOA?
The overall intent is to generate evidence-based, caregiver-centered interventions that support the caregiver as an individual while also measurably improving the patient-caregiver system in ways that translate into better health outcomes and more appropriate, efficient use of health care services.
Browse more opportunities from the same agency: HHS-NIH11
Browse more opportunities from the same category: Education, Health
Next opportunity: BLM OR/WA - San Juan Islands Terrestrial Managers Partnership
Previous opportunity: Geotechnical Fundamentals for Risk Reduction for Nepal Earthquake Professionals
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 16 317
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 16 317) also looked into and applied for these:
| Funding Opportunity |
|---|
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21) Apply for PAR 16 318 Funding Number: PAR 16 318 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03) Apply for PAR 16 337 Funding Number: PAR 16 337 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $50,000 |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21) Apply for PAR 16 336 Funding Number: PAR 16 336 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01) Apply for PAR 16 338 Funding Number: PAR 16 338 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01) Apply for RFA AA 17 006 Funding Number: RFA AA 17 006 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Cancer Target Discovery and Development Network (U01) Apply for RFA CA 16 014 Funding Number: RFA CA 16 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21) Apply for RFA CA 16 015 Funding Number: RFA CA 16 015 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Limited Competition: The Chernobyl Tissue Bank - Coordinating Center (U24) Apply for RFA CA 16 502 Funding Number: RFA CA 16 502 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24) Apply for RFA CA 16 017 Funding Number: RFA CA 16 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Research Centers for Population-based Research to Optimize Cancer Screening (PROSPR) Initiative (UM1) Apply for RFA CA 16 016 Funding Number: RFA CA 16 016 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| FY 2017 American Schools and Hospitals Abroad (ASHA) Program (Request for Comments) Apply for APS ASHA 17 000001 Funding Number: APS ASHA 17 000001 Agency: Agency for International Development Category: Education, Health Funding Amount: $2,000,000 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33) Apply for RFA CA 17 013 Funding Number: RFA CA 17 013 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) Apply for RFA CA 17 012 Funding Number: RFA CA 17 012 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) Apply for RFA CA 17 011 Funding Number: RFA CA 17 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24) Apply for RFA CA 17 004 Funding Number: RFA CA 17 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $650,000 |
| PDX Development and Trial Centers (PDTCs) (U54) Apply for RFA CA 17 003 Funding Number: RFA CA 17 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Mechanisms of Cancer Drug Resistance and Sensitivity (U54) Apply for RFA CA 17 009 Funding Number: RFA CA 17 009 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01) Apply for RFA CA 17 015 Funding Number: RFA CA 17 015 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24) Apply for RFA CA 17 016 Funding Number: RFA CA 17 016 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24) Apply for RFA CA 17 002 Funding Number: RFA CA 17 002 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 16 317", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.